Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzymeking Biotechnology is a China-based bio-enzyme manufacturer focused on the manufacture, supply, and research of natural enzymes and pharmaceutical raw materials. The company serves customers in pharmaceutical, health supplement, scientific research, food, and cosmetics markets, with products including proteolytic enzymes such as trypsin, chymotrypsin, pepsin, papain, bromelain, and aprotinin. Publicly available profiles emphasize its extraction and purification capabilities, export activity, and supply of high-purity enzyme ingredients rather than a therapeutic drug development pipeline. The company appears to operate commercial manufacturing facilities in Chifeng, Inner Mongolia, and markets itself as compliant with ISO 9001 and WHO GMP-related requirements. Overall, it is better characterized as an enzyme raw-materials supplier/API manufacturer than as a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzymeking Biotechnology.